Brief: European Medicines Agency Approves Nanexa's Clinical Trial Application For Phase I Study With NEX-22

Nanexa AB

15/05/2024 13:23

May 15 (Reuters) - Nanexa AB  NANEXA.ST :
    * EUROPEAN MEDICINES AGENCY HAS APPROVED COMPANY'S CLINICAL
TRIAL
APPLICATION FOR PHASE I STUDY WITH NEX-22

Source text for Eikon:  ID:nMFN9125pM 
Further company coverage:  NANEXA.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))